SAR445399
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAR445399, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]